- £124.08m
- £300.28m
- £440.60m
- 53
- 93
- 19
- 56
C2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 395 | 372 | 332 | 387 | 441 |
Cost of Revenue | |||||
Gross Profit | 214 | 214 | 185 | 221 | 219 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 359 | 349 | 319 | 352 | 430 |
Operating Profit | 35.9 | 22.3 | 13.7 | 34.8 | 10.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 28.7 | 16.1 | 8.3 | 29.1 | 1.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.2 | 12.2 | 6.1 | 21.4 | 1.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 23.2 | 16.8 | 9.5 | 21.6 | 1.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.2 | 16.8 | 9.5 | 21.6 | 1.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.046 | 0.042 | 0.034 | 0.047 | 0.043 |
Dividends per Share |